71 |
|
A primer on the economics of re-importation of prescription drugs
|
Berndt, E. R.
|
John Wiley & Sons, Ltd
|
2007
|
|
|
72 |
|
Managerial expertise, learning potential and dynamic incentives: get more for less?
|
Lukas, C.
|
John Wiley & Sons, Ltd
|
2007
|
|
|
73 |
|
Optimal price promotion in the presence of asymmetric reference-price effects
|
Fibich, G.; Gavious, A.; Lowengart, O.
|
John Wiley & Sons, Ltd
|
2007
|
|
|
74 |
|
Response to Tularam and Soomro
|
Vetschera, R.
|
John Wiley & Sons, Ltd
|
2007
|
|
|
75 |
|
Hidden monopsony rents in winner-take-all markets-sport and economic contribution of Spanish soccer players
|
Garcia-del-Barrio, P.; Pujol, F.
|
John Wiley & Sons, Ltd
|
2007
|
|
|
76 |
|
Patterns of corporate governance and technical efficiency in Italian manufacturing
|
Destefanis, S.; Sena, V.
|
John Wiley & Sons, Ltd
|
2007
|
|
|
77 |
|
Price rigidity and market power in German retailing
|
Weber, S. A.; Anders, S. M.
|
John Wiley & Sons, Ltd
|
2007
|
|
|
78 |
|
Product differentiation, competition and regulation of new drugs: the case of statins in four European countries
|
Kanavos, P.; Font, J. C.; McGuire, A.
|
John Wiley & Sons, Ltd
|
2007
|
|
|
79 |
|
Drug and vaccine pricing and innovation: what is the story?
|
Pauly, M. V.
|
John Wiley & Sons, Ltd
|
2007
|
|
|
80 |
|
Asymmetric price adjustment: evidence from weekly product-level scanner price data
|
Muller, G.; Ray, S.
|
John Wiley & Sons, Ltd
|
2007
|
|
|